EFM
NVAX icon

E Fund Management’s Novavax NVAX Stock Holding History

E Fund Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Sell
29,426
-1,800
-6% -$16.1K 0.01% 395
2026
Q1 		$254K Buy
+31,226
New +$283K 0.01% 414
2025
Q2 		$178K Buy
28,280
+2,326
+9% +$15.4K 0.01% 367
2025
Q1 		$166K Buy
25,954
+614
+2% +$5.08K 0.01% 371
2024
Q4 		$204K Buy
25,340
+1,219
+5% +$11.8K 0.01% 364
2024
Q3 		$305K Buy
24,121
+8,217
+52% +$106K 0.02% 260
2024
Q2 		$201K Sell
15,904
-63,610
-80% -$640K 0.01% 291
2024
Q1 		$380K Sell
79,514
-7,044
-8% -$32.7K 0.02% 233
2023
Q4 		$415K Buy
86,558
+35,581
+70% +$218K 0.03% 192
2023
Q3 		$369K Sell
50,977
-8,815
-15% -$70.4K 0.03% 180
2023
Q2 		$444K Buy
59,792
+561
+0.9% +$4.41K 0.04% 137
2023
Q1 		$410K Buy
59,231
+33,630
+131% +$309K 0.03% 157
2022
Q4 		$263K Buy
25,601
+10,584
+70% +$187K 0.02% 249
2022
Q3 		$273K Buy
15,017
+4,237
+39% +$184K 0.03% 248
2022
Q2 		$554K Buy
10,780
+7,104
+193% +$368K 0.05% 128
2022
Q1 		$271K Buy
+3,676
New +$328K 0.01% 234

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

E Fund Management's NVAX Position: Q2 2026 in Review

E Fund Management reduced its Novavax (NVAX) stake by 5.8% in Q2 2026, selling an estimated $16.1K and leaving 29,426 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #395.

E Fund Management first reported a position in NVAX in Q1 2022 and has held it in 16 quarters since. The position peaked at $554K in Q2 2022. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • E Fund Management held 29,426 shares of Novavax worth $277K as of Q2 2026.
  • E Fund Management sold 1,800 Novavax shares in Q2 2026, an estimated $16.1K.
  • Novavax made up 0.01% of E Fund Management's portfolio in Q2 2026, its #395 holding.
  • E Fund Management first reported a position in Novavax in Q1 2022 and has held it in 16 quarters since.
  • E Fund Management's Novavax position peaked at $554K in Q2 2022.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.